Search Clinical Trials
589,279 trials
ID
Status
Phase
Title
Sponsor
NCT07648498
Feasibility of a Community-Integrated Isometric Handgrip Exercise Program and Its Preliminary Effects on Blood Pressure and Cognitive Function in Older AdultsMcMaster UniversityNot Yet RecruitingNot Applicable
NCT07648498Not Yet Recruiting
Not Applicable
Feasibility of a Community-Integrated Isometric Handgrip Exercise Program and It...McMaster University
NCT07648069
Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced SarcomaSun Yat-sen UniversityRecruitingPhase 1
NCT07648069Recruiting
Phase 1
Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusi...Sun Yat-sen University
NCT07646652
Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body DiseaseStanford UniversityNot Yet Recruiting
NCT07646652Not Yet Recruiting
—
Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Sym...Stanford University
NCT07648264
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting TherapiesCSL BehringNot Yet RecruitingPhase 3
NCT07648264Not Yet Recruiting
Phase 3
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to...CSL Behring
NCT07646977
CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With ST-segment Elevation Myocardial Infarction (The CORMI Trial)Odense University HospitalNot Yet RecruitingNot Applicable
NCT07646977Not Yet Recruiting
Not Applicable
CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With...Odense University Hospita...
NCT07647783
A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2072 TabletsInnovStone Therapeutics LimitedRecruitingPhase 1
NCT07647783Recruiting
Phase 1
A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pha...InnovStone Therapeutics L...
NCT07648693
Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET TrialResonova (Shanghai) Medtech LimitedRecruitingNot Applicable
NCT07648693Recruiting
Not Applicable
Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System...Resonova (Shanghai) Medte...
NCT07648901
Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity and Cardiometabolic Health After Traumatic Brain InjuryBaylor Research InstituteNot Yet Recruiting
NCT07648901Not Yet Recruiting
—
Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity...Baylor Research Institute
NCT07647822
Comparison of Early Postoperative Functional Capacity and Kinesiophobia in Patients Undergoing Thoracic Surgery Via Thoracotomy or VATSHacettepe UniversityCompleted
NCT07647822Completed
—
Comparison of Early Postoperative Functional Capacity and Kinesiophobia in Patie...Hacettepe University
NCT07647874
Assessment of Spirulina Gel Prepared By Different Extraction Methods as an Adjunctive Therapy to Mechanical Debridement in the Treatment of Stage II Grade B PeriodontitisMansoura UniversityCompletedEarly Phase 1
NCT07647874Completed
Early Phase 1
Assessment of Spirulina Gel Prepared By Different Extraction Methods as an Adjun...Mansoura University
NCT07646860
A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)Merck Sharp & Dohme LLCNot Yet RecruitingPhase 2
NCT07646860Not Yet Recruiting
Phase 2
A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hy...Merck Sharp & Dohme LLC
NCT07647081
The Impacts of Ashwagandha Supplementation on Diurnal Cortisol and Stress Among WomenOklahoma State University Center for Health SciencesNot Yet RecruitingNot Applicable
NCT07647081Not Yet Recruiting
Not Applicable
The Impacts of Ashwagandha Supplementation on Diurnal Cortisol and Stress Among...Oklahoma State University...
NCT07647328
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast CancerAstraZenecaNot Yet RecruitingPhase 3
NCT07647328Not Yet Recruiting
Phase 3
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2...AstraZeneca
NCT07648953
Microvideos for Improving HPV Vaccination Among Childhood Cancer SurvivorsHuntsman Cancer InstituteRecruitingNot Applicable
NCT07648953Recruiting
Not Applicable
Microvideos for Improving HPV Vaccination Among Childhood Cancer SurvivorsHuntsman Cancer Institute
NCT07648667
Cognitive Task Sensitivity in Perimenopause and Nutritional StatusNorthumbria UniversityNot Yet Recruiting
NCT07648667Not Yet Recruiting
—
Cognitive Task Sensitivity in Perimenopause and Nutritional StatusNorthumbria University
NCT07647861
Efficacy of Lasers, Propolis-Based Agent, and Sham for Dentine HypersensitivityOndokuz Mayıs UniversityCompletedNot Applicable
NCT07647861Completed
Not Applicable
Efficacy of Lasers, Propolis-Based Agent, and Sham for Dentine HypersensitivityOndokuz Mayıs University
NCT07648524
Influence of Cardiopulmonary Rehabilitation on Cardiorespiratory Adaptation in Patients With Pulmonary HypertensionCairo UniversityNot Yet RecruitingNot Applicable
NCT07648524Not Yet Recruiting
Not Applicable
Influence of Cardiopulmonary Rehabilitation on Cardiorespiratory Adaptation in P...Cairo University
NCT07646678
A Study of TAK-360 in People With Narcolepsy or Idiopathic HypersomniaTakedaNot Yet RecruitingPhase 2
NCT07646678Not Yet Recruiting
Phase 2
A Study of TAK-360 in People With Narcolepsy or Idiopathic HypersomniaTakeda
NCT07648160
Contrast-enhanced CBCT With C-arm HyperSight TechnologyUniversity Health Network, TorontoNot Yet RecruitingNot Applicable
NCT07648160Not Yet Recruiting
Not Applicable
Contrast-enhanced CBCT With C-arm HyperSight TechnologyUniversity Health Network...
Result Breakdown
Not yet recruiting12 (60%)
Recruiting5 (25%)
Completed3 (15%)
not_applicable8 (40%)
Not Specified5 (25%)
Phase 12 (10%)
Phase 32 (10%)
Phase 22 (10%)
Early Phase 11 (5%)